Reliance Industries (RIL) shares will remain in focus on Monday after the company on Saturday announced the acquisition of technology-led oncology platform Karkinos Healthcare for Rs 375 crore ...

Most recently, RIL acquired oncology platform Karkinos Healthcare for Rs 375 crore, expanding its footprint in digital and diagnostic healthcare, PTI reported, citing a Morgan Stanley report.

Set up during the pandemic, Karkinos works with various healthcare institutions in the oncology ecosystem, a statement from the startup said. Rakuten Medical's first pipeline drug developed on its ...

were trading on a flat note in early deals on Monday even as the Mukesh-Ambani led conglomerate announced the acquisition of technology-led oncology platform Karkinos Healthcare for Rs 375 crore ...

Billionaire Mukesh Ambani's Reliance Industries has acquired technology-driven and oncology-focused healthcare platform Karkinos for Rs 375 crore, the firm said on Saturday. Reliance Strategic ...

Reliance Industries Limited has intensified its push into the healthcare sector with the acquisition of Karkinos Healthcare, an oncology platform, through its subsidiary Reliance Strategic Business ...

Recent acquisition Karkinos Healthcare boosts its digital healthcare presence. Major investments include Hathway Cable and REC Solar. RIL aims to enhance its healthcare services using advanced ...

The acquisition of the oncology platform Karkinos Healthcare by Reliance Industries Limited has added another stack to the Indian conglomerate's diagnostic and digital healthcare ecosystem ...

Reliance Industries Ltd, led by Mukesh Ambani, has invested $13 billion over five years to transition from its core oil business to new sectors like clean energy and healthcare. Significant ...

The development follows the approval of a resolution plan for Karkinos Healthcare by NCLT after it entered the Corporate Insolvency Resolution Process (CIRP) in May. Tata Group to invest Rs 110 ...

Karkinos was incorporated in India on July 24, 2020, and is in the business of providing technology-driven innovative solutions for the early detection, diagnosis, and management of cancer.